MARS®: A futile tool in centres without active liver transplant support

Liver International

Volumn 27, Issue 1, 2007, Pages 69-75

  Wai, Chun Tao ^a   Lim, Seng Gee ^a   Aung, Myot Oo ^a   Lee, Yin Mei ^a   Sutedja, Dede S ^b   Dan, Yock Young ^b   Aw, Marion M ^c   Quak, Seng Hock ^c   Lee, Margaret K ^b   Da Costa, Maureen ^b   Prahbakaran, K ^b   Lee, Kang Hoe ^a  

^a Dept Medicine Endocrinol Diabet   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Encephalopathy; Liver cirrhosis; Liver dialysis; Liver failure

Indexed keywords

ANTIBIOTIC AGENT; LACTULOSE; LAMIVUDINE; METHOTREXATE; PROTON PUMP INHIBITOR;

ADULT; AGED; ALBUMIN DIALYSIS; ARTICLE; CADAVER DONOR; CHILD; CLINICAL EFFECTIVENESS; DISEASE EXACERBATION; FEMALE; GRAFT SURVIVAL; HEPATITIS B; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER INJURY; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEPSIS; UPPER GASTROINTESTINAL BLEEDING; ARTIFICIAL LIVER; MIDDLE AGED;

ADULT; AGED; CHILD; FEMALE; HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; MALE; MIDDLE AGED;

EID: 33846441700     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2006.01388.x     Document Type: Article

References (24)

1. Jalan R. Acute liver failure: Current management and future prospects. J Hepatol 2005; 42 (1 Suppl.): S115-23.
2. O'Grady J. Personal view: Current role of artificial liver support devices. Aliment Pharmacol Ther 2006; 23: 1549-57.
3. Doria C, Mandala L, Scott VL, Gruttadauria S, Marino IR. Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: A single-center experience. Dig Dis Sci 2006; 51: 47-53.
4. Ding YT, Xu QX, Qiu YD, Yang YJ. Molecular adsorbent recycling system in treating patients with acute liver failure: A bridge to liver transplantation. Hepatobiliary Pancreat Dis Int 2004; 3: 508-10.
5. Mitzner SR, Stange J, Klammt S, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transplant 2000; 6: 277-86.
6. Sen S, Davies NA, Mookerjee RP, et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: A randomized controlled study. Liver Transplant 2004; 10: 1109-19.
7. Hessel FP, Mitzner SR, Rief J, Guellstorff B, Steiner S, Wasem J. Economic evaluation and 1-year survival analysis of MARS in patients with alcoholic liver disease. Liver Int 2003; 23 (Suppl. 3): 66-72.
8. Choi JY, Bae SH, Yoon SK, et al. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation - a pilot study. Liver Int 2005; 25: 740-5.
9. Stefoni S, Coli L, Bolondi L, et al. Molecular absorbent recycling system (MARS) application in liver failure: Clinical and hemodepurative results in 22 patients. Int J Artif Organs 2006; 29: 207-18.
10. Khuroo MS, Khuroo MS, Farahat KL. Molecular adsorbent recirculating system for acute and acute-on-chronic liver failure: A meta-analysis. Liver Transplant 2004; 10: 1099-106.
11. Hassanein T, Tofteng F, Brown RS, et al. Efficacy of albumin dialysis (MARS) in patients with cirrhosis and advanced grades of hepatic encephalopathy: A prospective, controlled, randomized, multicenter trial. Hepatology 2004; 40: 762A.
12. Kamath PS. Is there life in MARS? Hepatology 2002; 36: 1017-9.
13. Wai CT, Lo SK, Lee KH, et al. Ten years of experience of liver transplantation in Singapore. Transplant Proc 2000; 32: 2139.
14. Lee KH, Lee MK, Sutedja DS, Lim SG. Outcome from molecular adsorbent recycling system (MARS) liver dialysis following drug-induced liver failure. Liver Int 2005; 25: 973-7.
15. Khoo AL, Tham LS, Lim GK, Lee KH. Hypoglycemia in nondiabetic patients undergoing albumin dialysis by molecular adsorbent recirculating system. Liver Transplant 2003; 9: 949-53.
16. Wai CT, Lee YM, Selamat DS, et al. Liver transplantation in Singapore 1990-2004. Singapore Med J 2006; 47: 580-3.
17. Singapore Ministry of Health. Medisave, medishield and other subsidy schemes: Overview. http://www.moh.gov.sg/corp/financing/overview.do.
18. Polson J, Lee WM. AASLD position paper: The management of acute liver failure. Hepatology 2005; 41: 1179-97.
19. Sen S, Williams R, Jalan R. The pathophysiological basis of acute-on-chronic liver failure. Liver 2002; 22 (Suppl. 2): 5-13.
20. Sen S, Williams R, Jalan R. Emerging indications for albumin dialysis. Am J Gastroenterol 2005; 100: 468-75.
21. Saliba F. The Molecular Adsorbent Recirculating System (MARS(R)) in the intensive care unit: A rescue therapy for patients with hepatic failure. Crit Care 2006; 10: 118.
22. de Villa VH, Lo CM, Chen CL. Ethics and rationale of living-donor liver transplantation in Asia. Transplantation 2003; 75: S2-5.
23. Broering DC, Sterneck M, Rogiers X. Living donor liver transplantation. J Hepatol 2003; 38 (Suppl. 1): S119-35.
24. Brown RS Jr. MARS preconditioning for living donor liver transplantation: Panacea or placebo? Liver Int 2005; 25: 692-5.